Case Study: Biopharma achieves 40% faster test case creation with Forte Group's AI-powered QA automation

Biopharma cuts test creation time by 40% with Forte Group

The customer, a biopharma company, faced a strained manual QA process that slowed test case creation, created compliance risks, and delayed the rollout of new therapies. Forte Group addressed these challenges by developing an AI-powered Test Automation Assistant to streamline their quality assurance processes.

Forte Group's solution used AI to automatically generate test cases from requirements, validate coverage, and provide complete audit trails. This implementation resulted in a 40% reduction in test authoring time, $2.4 million in annual labor savings, and accelerated time-to-market for new therapies while ensuring audit-ready compliance.